Still, those effects are tolerable for a lot of people. And McDermott said it might be worthwhile to ask your doctor about the pros and cons of the drug. "Patients with PAD and (leg pain) may want to discuss ramipril with their doctor as a potential therapeutic option to improve their walking," she said.
The study was funded by the National Heart Foundation of Australia and government grants. Several of the study authors reported ties with drug companies.
Learn more about peripheral artery disease from the American Heart Association.
Copyright © 2012 HealthDay. All rights reserved.